Therefore, our data are in line with a recent functional study demonstrating that methylation-dependent silencing of GATA3 expression is correlated with the loss of transforming growth factor-β receptor III and tumorigenesis in ccRCC tissues and cell lines, although its role in disease progression and patient survival remained to be elucidated (25). Here, GATA3 is linked to nonpapillary renal cell carcinoma.